Vivo Bio Tech Ltd share price logo

Vivo Bio Tech Ltd

BSE: 511509

Small Cap

Pharma Sector

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

Vivo Bio Tech Stock Performance

as on January 1, 1901 at 5:21 am IST

Vivo Bio Tech share price movements today

Previous Close
-
Open
-
Volume
0.00
Upper Circuit
-
Lower Circuit
-

Vivo Bio Tech Historical Returns

1 Month Return
-13.99 %
3 Month Return
-27.07 %
1 Year Return
-45.25 %
3 Year Return
-26.64 %
5 Year Return
-75.47 %

Vivo Bio Tech Fundamentals

as on August 8, 1994 at 12:00 am IST

Market Cap

₹44.60 Cr

Return on Equity (ROE)

6.05

PE Ratio (TTM)

-14.06

Return on capital employed (ROCE)

9.37

Industry PE ratio

51.63

Beta (LTM)

1.01

P/B Ratio

0.82

Dividend Yield

0

PEG Ratio

2.03

Quarterly Earnings Growth YOY

-85.82

EPS (TTM)

4.24

Book Value

41.15

Vivo Bio Tech Stock Valuation

as on August 8, 1994 at 12:00 am IST

Vivo Bio Tech in the last 5 years

  • Overview

  • Trends

Lowest (-339.44x)

January 2, 2023

Today (-14.06x)

August 14, 2026

Industry (51.63x)

August 14, 2026

Highest (48.33x)

October 31, 2022

LowHigh

Today’s Price to Earnings Ratio: -14.06x

Vivo Bio Tech Technical Analysis

Track how Vivo Bio Tech technical analysis has moved over time to understand its trends.

1 min
5 min
15 min
30 min
1 day
1 week
1 month

Technicals Summary

Bearish

Neutral

Bullish

Bullish

Moving Averages

Bearish

Neutral

Bullish

Bullish

Oscillators

Bearish

Neutral

Bullish

Bullish

Overall

Bearish
Bullish12
Neutral3

Oscillators

Name

Value

Action

MACD level (12,26)
0.04
Bullish
CCI (20)
24.29
Neutral
RSI (14)
64.17
Neutral
Momentum (10)
0.32
Neutral
ADI (14)
33.43
Bullish
Ultimate Oscillator (7,14,28)
79.12
Bullish

Moving Averages

Name

Value

Action

SMA (20)
20.28
Bullish
EMA (20)
20.33
Bullish
VWMA (20)
20.32
Bullish
SMA (50)
20.33
Bullish
EMA (50)
20.32
Bullish
SMA (200)
20.33
Bullish
EMA (200)
20.32
Bullish
KAMA (200)
20.23
Bullish
DEMA (200)
20.32
Bullish

Vivo Bio Tech Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Vivo Bio Tech with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Vivo Bio Tech Ltd image
Vivo Bio Tech Ltd
NA44.60-15.09%0.71746
Gufic BioSciences Ltd image
Gufic BioSciences Ltd
NA4,233.9318.81%0.6969819
Cian Healthcare Ltd image
Cian Healthcare Ltd
NA23.88-8.83%0.82-2630
Shelter Pharma Ltd image
Shelter Pharma Ltd
NA42.43-7.99%0.00750
Pentokey Organy (India) Ltd image
Pentokey Organy (India) Ltd
NA23.0318.97%0.0034
See all

Vivo Bio Tech Stock’s Investor Sentiment and Interest

Search interest for Vivo Bio Tech Ltd Stock has increased by 23% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:23% versus previous 30 day period

Vivo Bio Tech Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Sales
9.26
12.85
11.76
10.13
12.04
12.21
12.29
12.51
13.11
13.51
14.2
14.28
Other Income
-
0.03
0.01
0.01
4.63
0.01
0.15
0.14
0.13
0.14
0.03
0.06
Total Income
9.26
12.88
11.77
10.15
16.67
12.22
12.44
12.65
13.24
13.65
14.23
14.34
Expenses
4.4
6.47
6.39
5.77
6.44
6.67
7.28
7.02
7.7
8.02
9.75
9.23
Operating Profit
4.86
6.38
5.37
4.36
5.6
5.54
5.01
5.49
5.41
5.49
4.45
5.05
Operating Profit Margin %
52.48%
49.65%
45.66%
43.04%
46.51%
45.37%
40.76%
43.88%
41.27%
40.64%
31.34%
35.36%
Profit Before Interest, Tax and Depreciation
4.86
6.41
5.38
4.38
10.22
5.55
5.17
5.63
5.55
5.63
4.48
5.11
Interest
2.09
2.22
1.52
1.92
2.06
1.84
1.68
1.5
1.47
1.4
1.48
1.24
Depreciation
2.3
2.28
2.43
2.23
2.29
2.25
2.25
2.64
2.57
2.66
2.75
3.53
Profit Before Tax
0.47
1.91
1.43
0.23
5.87
1.46
1.24
1.49
1.51
1.57
0.25
0.34
Tax Paid
0.14
0.59
0.7
0.06
0.63
0.64
0.18
0.14
0.64
0.32
5.41
0.15
Profit After Tax
0.33
1.32
0.74
0.17
5.23
0.82
1.06
1.34
0.87
1.25
-5.16
0.19
Total Net profit including share of profit / Loss from associate company
0.33
1.32
0.74
0.17
5.23
0.82
1.06
1.34
0.87
1.25
-5.16
0.19
EPS
0.22
0.89
0.5
0.11
3.51
0.55
0.69
0.74
0.45
0.56
-2.52
0.08
Actual EPS
0.22
0.89
0.5
0.11
3.51
0.55
0.69
0.74
0.45
0.56
-2.52
0.08
Adjusted EPS
0.22
0.89
0.5
0.11
3.51
0.55
0.69
0.74
0.45
0.56
-2.52
0.08
Diluted EPS
0.22
0.89
0.31
0.11
3.51
0.55
0.69
0.74
0.45
0.56
-2.52
0.08

Vivo Bio Tech Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Sales
47
55.83
55.35
51.78
51.39
52.23
45.45
46.67
53.33
Other Income
0.13
0.01
0.05
0.08
0.1
0.04
0.04
4.8
0.44
Total Income
47.13
55.85
55.41
51.85
51.49
52.27
45.49
51.48
53.78
Expenses
36.12
46.32
42.88
34.11
35.58
30.73
24.36
26.16
32.49
Operating Profit
10.88
9.51
12.47
17.67
15.81
21.5
21.09
20.51
20.84
Operating Profit Margin %
23.15%
17.03%
22.53%
34.13%
30.76%
41.16%
46.4%
43.95%
39.08%
Profit Before Interest, Tax and Depreciation
11.01
9.53
12.52
17.74
15.91
21.54
21.13
25.31
21.29
Interest
2.37
2.64
3.1
3.53
3.99
7.65
7.78
7.5
5.85
Depreciation
4.64
5.06
5.17
5.59
7.45
9.27
9.29
9.02
10.63
Profit Before Tax
4
1.83
4.25
8.62
4.47
4.62
4.06
8.79
4.81
Tax Paid
0.88
-0.42
-0.19
2.94
2.27
1.97
1.54
1.51
6.52
Profit After Tax
3.12
2.25
4.44
5.68
2.2
2.65
2.53
7.28
-1.71
Total Net profit including share of profit / Loss from associate company
3.12
2.25
4.44
5.68
2.2
2.65
2.53
7.28
-1.71
EPS
3.18
1.82
3.45
4.23
1.56
1.78
1.7
4.76
-0.82
Actual EPS
3.18
1.82
3.45
4.23
1.56
1.78
1.7
4.76
-0.82
Adjusted EPS
3.18
1.82
3.45
4.23
1.56
1.78
1.7
4.76
-0.82
Diluted EPS
2.36
1.76
3.45
4.19
1.56
1.78
1.51
4.76
-0.82

Vivo Bio Tech Ltd Cash Flow

Figures in Rupees Crores

Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Net Cash from Operating Activities
8.81
-5.66
11.11
-0.78
8.61
14.18
16.64
14.83
15.52
11.83
Cash Flow from Investing Activities
-7.2
-11.84
-4.72
-3.53
-10.23
-22.82
-51.11
-4
-7.95
-15.84
Cash Flow from Financing Activities
-0.32
6.83
-3.43
0.72
2.09
8.78
35.02
-11.17
-7.55
3.9
Net Cash Flow
1.3
-10.67
2.96
-3.59
0.47
0.14
0.55
-0.34
0.01
-0.11

Vivo Bio Tech Stock Shareholding Pattern

Numbers in percentages

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Apr 2025
May 2025
Jun 2025
Aug 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Promoters
42.08%
42.08%
42.08%
42.08%
42.08%
38.88%
40.85%
43.36%
42.29%
39.06%
36.43%
35.16%
35.16%
35.43%
30.62%
Public
57.92%
57.92%
57.92%
57.92%
57.92%
61.12%
59.15%
56.64%
57.71%
60.94%
63.57%
64.84%
64.84%
64.57%
69.38%
Total Outstanding Shares
1,49,03,520
1,49,03,520
1,49,03,520
1,49,03,520
1,49,03,520
1,61,28,520
1,71,64,816
1,79,24,816
1,83,78,149
1,98,93,889
2,13,33,221
2,21,00,628
2,21,00,628
2,21,90,628
2,21,90,628
Total Shareholders
13,006
15,615
18,971
18,852
19,545
21,167
21,935
21,935
21,909
21,865
21,890
21,647
21,622
21,427
21,224

Vivo Bio Tech Corporate Actions

View detailed summary of the earnings and dividend history of Vivo Bio Tech.

  • Vivo Bio Tech Ltd Earnings Results

    Vivo Bio Tech Ltd’s net profit fell -85.82% since last year same period to ₹0.19Cr in the Q1 2026-2027. On a quarterly growth basis, Vivo Bio Tech Ltd has generated 103.68% jump in its net profits since last 3-months.

    Read More about Earnings Results

Insights on Vivo Bio Tech Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 7 quarters, 12.22 Cr → 14.34 Cr (in ₹), with an average increase of 2.6% per quarter

  • imgPOSITIVE IMPACT

    Retail Holding Up

    img

    Retail Investor have increased holdings from 64.57% to 69.38% in Jun 2026 quarter

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, -5.16 Cr → 0.19 Cr (in ₹), with an average increase of 2815.8% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Biocon Ltd has given 14.5% return, outperforming this stock by 59.7%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Vimta Labs Ltd has given 136.7% return, outperforming this stock by 163.3%

  • imgNEGATIVE IMPACT

    Promoter Holding Down

    img

    Promoters have decreased holdings from 35.43% to 30.62% in Jun 2026 quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, Vivo Bio Tech stock has moved down by -6.5%

About Vivo Bio Tech Ltd

Vivo Bio Tech is a full service CRO that provides a range of drug development and discovery services tailored to the needs of global pharmaceutical and biotechnology companies in accordance with OECD AAALAC IND guidelines. With experienced and talented scientists, our services include In vitro and In vivo toxicity studies, pharmacological investigations, pharmacokinetics, toxicokinetic studies, gene synthesis, cloning, expression and purification of recombinant proteins and monoclonal antibodies. Additionally, we offer services for pharmacologic, toxicological and bioanalytical investigations for drug discovery and development, including bacterial reverse mutation assays, chromosomal aberration and micronucleus. Our Invivo Services group provides both nonregulatory and regulatory IND enabling preclinical development services as well as design and development of xenograft models for evaluation of anticancer agents. We have also partnered with Taconic for sourcing foundation and expansion colonies of animal models, in addition to beginning in-house breeding of Specific Pathogen Free rodents.

Revenue: ₹14.28Cr as on June 2026 (Q1 FY27)
Net Profit: ₹0.19Cr as on June 2026 (Q1 FY27)
Chairperson Name: K Sunder
OrganisationVivo Bio Tech Ltd
HeadquartersSecunderabad
IndustryPharmaceuticals
CEOK Sunder
E-voting on sharesClick here to vote